Künstliche Intelligenz in der Krebstherapie
- Autores
- Kalweit, Gabriel; Kalweit, Maria; Mastroleo, Ignacio Damian; Bödecker, Joschka; Mertelsmann, Roland
- Año de publicación
- 2023
- Idioma
- alemán
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The number of computer and data-supported tools is increasing rapidly in the field of oncology. Corresponding methods are finding their way into almost all areas of application, from diagnostic systems and tumor modeling to the prognosis of disease progression. However, the sheer combinatorial complexity of this disease, which results from more potential combinations of cancerous mutations than atoms in the universe, leads to the need for individually optimized cancer treatment for each patient. The use of artificial intelligence to optimize therapeutic interventions aimed at controlling cancer within clinically meaningful limits is still a very uncharted territory that has rarely been explored beyond pure in silico experiments. In this manuscript, we explain the basics of artificial intelligence, show some applications already established today, give a vision of an AI-controlled therapeutic system and briefly discuss some general ethical considerations.
Fil: Kalweit, Gabriel. Colaborative Research Inst. Inteligent Oncology Criion; Alemania. Albert Ludwigs University of Freiburg; Alemania
Fil: Kalweit, Maria. Albert Ludwigs University of Freiburg; Alemania. Colaborative Research Inst. Inteligent Oncology Criion; Alemania
Fil: Mastroleo, Ignacio Damian. Colaborative Research Inst. Inteligent Oncology Criion; Alemania. Facultad Latinoamericana de Ciencias Sociales; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Bödecker, Joschka. Albert Ludwigs University of Freiburg; Alemania
Fil: Mertelsmann, Roland. Albert Ludwigs University of Freiburg; Alemania - Materia
-
ARTIFICIAL INTELLIGENCE
CANCER MEDICAL TREATMENT
CANCER RESEARCH
MACHINE LEARNING
REINFORCED LEARNING
ETHICAL CONSIDERATIONS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/229788
Ver los metadatos del registro completo
id |
CONICETDig_de6a462ee1b9fe79110bcf908ca55a4e |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/229788 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Künstliche Intelligenz in der KrebstherapieArtificial Intelligence in cancer therapyKalweit, GabrielKalweit, MariaMastroleo, Ignacio DamianBödecker, JoschkaMertelsmann, RolandARTIFICIAL INTELLIGENCECANCER MEDICAL TREATMENTCANCER RESEARCHMACHINE LEARNINGREINFORCED LEARNINGETHICAL CONSIDERATIONShttps://purl.org/becyt/ford/6.3https://purl.org/becyt/ford/6https://purl.org/becyt/ford/3.4https://purl.org/becyt/ford/3https://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3The number of computer and data-supported tools is increasing rapidly in the field of oncology. Corresponding methods are finding their way into almost all areas of application, from diagnostic systems and tumor modeling to the prognosis of disease progression. However, the sheer combinatorial complexity of this disease, which results from more potential combinations of cancerous mutations than atoms in the universe, leads to the need for individually optimized cancer treatment for each patient. The use of artificial intelligence to optimize therapeutic interventions aimed at controlling cancer within clinically meaningful limits is still a very uncharted territory that has rarely been explored beyond pure in silico experiments. In this manuscript, we explain the basics of artificial intelligence, show some applications already established today, give a vision of an AI-controlled therapeutic system and briefly discuss some general ethical considerations.Fil: Kalweit, Gabriel. Colaborative Research Inst. Inteligent Oncology Criion; Alemania. Albert Ludwigs University of Freiburg; AlemaniaFil: Kalweit, Maria. Albert Ludwigs University of Freiburg; Alemania. Colaborative Research Inst. Inteligent Oncology Criion; AlemaniaFil: Mastroleo, Ignacio Damian. Colaborative Research Inst. Inteligent Oncology Criion; Alemania. Facultad Latinoamericana de Ciencias Sociales; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Bödecker, Joschka. Albert Ludwigs University of Freiburg; AlemaniaFil: Mertelsmann, Roland. Albert Ludwigs University of Freiburg; AlemaniaUniversity of Freiburg2023-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/229788Kalweit, Gabriel; Kalweit, Maria; Mastroleo, Ignacio Damian; Bödecker, Joschka; Mertelsmann, Roland; Künstliche Intelligenz in der Krebstherapie; University of Freiburg; Ordnung der Wissenschaft; 1; 10-2023; 17-222197-9197CONICET DigitalCONICETdeuinfo:eu-repo/semantics/altIdentifier/url/https://ordnungderwissenschaft.de/wp-content/uploads/2022/12/02_01_mertelsmann.pdfinfo:eu-repo/semantics/altIdentifier/doi/10.17176/20221219-115557-0info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:45:13Zoai:ri.conicet.gov.ar:11336/229788instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:45:14.114CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Künstliche Intelligenz in der Krebstherapie Artificial Intelligence in cancer therapy |
title |
Künstliche Intelligenz in der Krebstherapie |
spellingShingle |
Künstliche Intelligenz in der Krebstherapie Kalweit, Gabriel ARTIFICIAL INTELLIGENCE CANCER MEDICAL TREATMENT CANCER RESEARCH MACHINE LEARNING REINFORCED LEARNING ETHICAL CONSIDERATIONS |
title_short |
Künstliche Intelligenz in der Krebstherapie |
title_full |
Künstliche Intelligenz in der Krebstherapie |
title_fullStr |
Künstliche Intelligenz in der Krebstherapie |
title_full_unstemmed |
Künstliche Intelligenz in der Krebstherapie |
title_sort |
Künstliche Intelligenz in der Krebstherapie |
dc.creator.none.fl_str_mv |
Kalweit, Gabriel Kalweit, Maria Mastroleo, Ignacio Damian Bödecker, Joschka Mertelsmann, Roland |
author |
Kalweit, Gabriel |
author_facet |
Kalweit, Gabriel Kalweit, Maria Mastroleo, Ignacio Damian Bödecker, Joschka Mertelsmann, Roland |
author_role |
author |
author2 |
Kalweit, Maria Mastroleo, Ignacio Damian Bödecker, Joschka Mertelsmann, Roland |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
ARTIFICIAL INTELLIGENCE CANCER MEDICAL TREATMENT CANCER RESEARCH MACHINE LEARNING REINFORCED LEARNING ETHICAL CONSIDERATIONS |
topic |
ARTIFICIAL INTELLIGENCE CANCER MEDICAL TREATMENT CANCER RESEARCH MACHINE LEARNING REINFORCED LEARNING ETHICAL CONSIDERATIONS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/6.3 https://purl.org/becyt/ford/6 https://purl.org/becyt/ford/3.4 https://purl.org/becyt/ford/3 https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
The number of computer and data-supported tools is increasing rapidly in the field of oncology. Corresponding methods are finding their way into almost all areas of application, from diagnostic systems and tumor modeling to the prognosis of disease progression. However, the sheer combinatorial complexity of this disease, which results from more potential combinations of cancerous mutations than atoms in the universe, leads to the need for individually optimized cancer treatment for each patient. The use of artificial intelligence to optimize therapeutic interventions aimed at controlling cancer within clinically meaningful limits is still a very uncharted territory that has rarely been explored beyond pure in silico experiments. In this manuscript, we explain the basics of artificial intelligence, show some applications already established today, give a vision of an AI-controlled therapeutic system and briefly discuss some general ethical considerations. Fil: Kalweit, Gabriel. Colaborative Research Inst. Inteligent Oncology Criion; Alemania. Albert Ludwigs University of Freiburg; Alemania Fil: Kalweit, Maria. Albert Ludwigs University of Freiburg; Alemania. Colaborative Research Inst. Inteligent Oncology Criion; Alemania Fil: Mastroleo, Ignacio Damian. Colaborative Research Inst. Inteligent Oncology Criion; Alemania. Facultad Latinoamericana de Ciencias Sociales; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Bödecker, Joschka. Albert Ludwigs University of Freiburg; Alemania Fil: Mertelsmann, Roland. Albert Ludwigs University of Freiburg; Alemania |
description |
The number of computer and data-supported tools is increasing rapidly in the field of oncology. Corresponding methods are finding their way into almost all areas of application, from diagnostic systems and tumor modeling to the prognosis of disease progression. However, the sheer combinatorial complexity of this disease, which results from more potential combinations of cancerous mutations than atoms in the universe, leads to the need for individually optimized cancer treatment for each patient. The use of artificial intelligence to optimize therapeutic interventions aimed at controlling cancer within clinically meaningful limits is still a very uncharted territory that has rarely been explored beyond pure in silico experiments. In this manuscript, we explain the basics of artificial intelligence, show some applications already established today, give a vision of an AI-controlled therapeutic system and briefly discuss some general ethical considerations. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-10 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/229788 Kalweit, Gabriel; Kalweit, Maria; Mastroleo, Ignacio Damian; Bödecker, Joschka; Mertelsmann, Roland; Künstliche Intelligenz in der Krebstherapie; University of Freiburg; Ordnung der Wissenschaft; 1; 10-2023; 17-22 2197-9197 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/229788 |
identifier_str_mv |
Kalweit, Gabriel; Kalweit, Maria; Mastroleo, Ignacio Damian; Bödecker, Joschka; Mertelsmann, Roland; Künstliche Intelligenz in der Krebstherapie; University of Freiburg; Ordnung der Wissenschaft; 1; 10-2023; 17-22 2197-9197 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
deu |
language |
deu |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://ordnungderwissenschaft.de/wp-content/uploads/2022/12/02_01_mertelsmann.pdf info:eu-repo/semantics/altIdentifier/doi/10.17176/20221219-115557-0 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
University of Freiburg |
publisher.none.fl_str_mv |
University of Freiburg |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613420516638720 |
score |
13.070432 |